Kyntra Bio (KYNB)

• Market cap: $27.9M
• 1 day: -1.71%
• 5 days: 1.17%
• 1 month: -2.13%
• 3 months: -2.13%
• 6 months: -19.11%
• Year to date: -24.67%
• 1 year: -13.21%
• 5 years: -98.74%
• 10 years: -98.52%
• Sector: Healthcare
• Industry: Biotechnology

About: Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Employees: 34